Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
04:06:31 EDT Thu 02 May 2024
Enter Symbol
or Name
USA
CA



News for U:INAB from 2023-05-03 to 2024-05-02 - 32 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-30 06:05U:INABNews ReleaseIN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma
2024-04-24 08:00U:INABNews ReleaseIN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
2024-04-16 16:05U:INABNews ReleaseIN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
2024-04-09 16:30U:INABNews ReleaseIN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024
2024-03-14 16:00U:INABNews ReleaseIN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
2024-03-05 16:30U:INABNews ReleaseIN8bio to Present New Preclinical Data on Novel Gamma-Delta CAR Platform Candidate at AACR Annual Meeting 2024
2024-02-26 08:00U:INABNews ReleaseIN8bio to Present at Upcoming Investor Conferences
2024-02-14 08:00U:INABNews ReleaseIN8bio Announces Publication on Novel Gamma-Delta T Cell Therapy for Glioblastoma in Frontiers in Immunology
2024-01-04 08:00U:INABNews ReleaseIN8bio Highlights Recent Company Accomplishments and Outlines 2024 Pipeline Goals
2023-12-11 16:05U:INABNews ReleaseIN8bio Announces Positive Clinical Update Demonstrating Continued Durable Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100 in Leukemia
2023-12-11 09:01U:INABNews ReleaseIN8bio Announces Pricing of Financing Totaling up to $46.9 Million in Private Placement
2023-12-07 08:00U:INABNews ReleaseIN8bio Appoints Dr. Corinne Epperly to Board of Directors
2023-12-05 08:00U:INABNews ReleaseIN8bio to Host Investor Call at 8:30 AM ET on Tuesday, December 12 to Discuss Updated Clinical Data from Phase 1 Trial of INB-100 in Patients with Leukemia
2023-11-20 07:00U:INABNews ReleaseIN8bio ¢ € ™s INB-200 Demonstrates Extended Progression-Free Survival in Patients with Newly Diagnosed Glioblastoma
2023-11-10 07:00U:INABNews ReleaseIN8bio to Present Data Highlighting Potential of INB-200 and INB-400 to Treat Patients with Newly Diagnosed Glioblastoma Multiforme at Society for Neuro-Oncology 28th Annual Meeting
2023-11-09 16:00U:INABNews ReleaseIN8bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
2023-11-06 08:00U:INABNews ReleaseIN8bio Presents Biologic Correlative Data from the INB-200 Phase 1 Trial in Newly Diagnosed Glioblastoma at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
2023-11-03 12:00U:INABNews ReleaseIN8bio Presents Positive Data Update from Induced Pluripotent Stem Cell (iPSC) Platform at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
2023-11-02 09:17U:INABNews ReleaseIN8bio to Present New Positive Data from Phase 1 Trial of INB-100 at 2023 American Society of Hematology (ASH) Annual Meeting
2023-11-01 08:00U:INABNews ReleaseIN8bio to Participate at the 2023 Truist Securities BioPharma Symposium
2023-10-12 08:00U:INABNews ReleaseIN8bio Completes Dose Escalation in Phase 1 Trial of INB-100, a Potential First-in-Class Gamma-Delta T Cell Therapy for the Treatment of Leukemias, and Initiates Enrollment for the Phase 2 Trial of INB-400 in Newly Diagnosed Glioblastoma
2023-09-29 08:00U:INABNews ReleaseIN8bio Announces Presentations at the Society for Immunology of Cancer (SITC) 38th Annual Meeting
2023-09-26 08:00U:INABNews ReleaseIN8bio to Host Research & Development Day on its Gamma-Delta T cell Therapies on Thursday, October 12, 2023 in New York City
2023-09-20 08:00U:INABNews ReleaseIN8bio to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference
2023-09-19 08:04U:INABNews ReleaseIN8bio Strengthens Intellectual Property Portfolio with Newly Granted Global Patents
2023-09-06 08:00U:INABNews ReleaseIN8bio to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
2023-08-15 08:00U:INABNews ReleaseIN8bio to Present at the H.C. Wainwright Immune Cell Engager Virtual Conference
2023-08-10 16:16U:INABNews ReleaseIN8bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update
2023-08-08 08:00U:INABNews ReleaseIN8bio Expands Capabilities with the Grand Opening of its Advanced Research and Development Facility
2023-06-05 08:00U:INABNews ReleaseIN8bio Announces Positive INB-200 Phase 1 Data Update in Glioblastoma at the 2023 ASCO Annual Meeting
2023-05-17 08:00U:INABNews ReleaseIN8bio's DeltEx Gamma-Delta T Cells Show Promise in Targeting Ovarian Cancer
2023-05-12 08:00U:INABNews ReleaseIN8bio Reports First Quarter 2023 Financial Results and Provides Corporate Update